Sichuan Kelun Pharmaceutical (002422.SZ): Xituximab N01 injection approved for market launch.

19:24 07/02/2025

Kolun Pharmaceutical (002422.SZ) announced that its subsidiary Sichuan Kolun Botai Biopharmaceutical Co., Ltd.

Sichuan Kelun Pharmaceutical (002422.SZ) announced that its subsidiary Sichuan Kelun Botai Biopharmaceutical Co., Ltd.'s recombinant epidermal growth factor receptor (EGFR) human-mouse chimeric monoclonal antibody - cetuximab injection (formerly known as A140) (Detelai) has been approved by China's National Medical Products Administration (NMPA) for listing in China. It is indicated for use in combination with FOLFOX or FOLFIRI regimens for first-line treatment of RAS wild-type metastatic colorectal cancer, at a dose of 500mg/m2 once every two weeks, or an initial dose of 400mg/m2 followed by a maintenance dose of 250mg/m2 once a week.

Is Palantir (PLTR.US) becoming the "arms giant" of the AI era? The Pentagon wants to integrate Maven AI into the heart of US military operations.

United Airlines (UAL.US) plans to reduce flights by 5% as high oil prices erode profits, entering into a battle to defend profitability in the aviation industry.

Energy storage is Token, GUOXIA TECH (02655) 2025 full-year performance greatly exceeds expectations, income soars as AI computing power demand increases exponentially!

Is Palantir (PLTR.US) becoming the "arms giant" of the AI era? The Pentagon wants to integrate Maven AI into the heart of US military operations.

United Airlines (UAL.US) plans to reduce flights by 5% as high oil prices erode profits, entering into a battle to defend profitability in the aviation industry.

Energy storage is Token, GUOXIA TECH (02655) 2025 full-year performance greatly exceeds expectations, income soars as AI computing power demand increases exponentially!